We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioTek

BioTek Instruments, Inc., designs, manufactures, and distributes life science instrumentation. Its product line inclu... read more Featured Products: More products

Download Mobile App




New Digital Microscope Boasts Augmented Software

By LabMedica International staff writers
Posted on 08 Jun 2017
Print article
Image: The Cytation 1 cell imaging multimode reader (Photo courtesy of BioTek Instruments).
Image: The Cytation 1 cell imaging multimode reader (Photo courtesy of BioTek Instruments).
A new automated digital quantitative multi-mode microscope has been released for use by biotech and other life science researchers.

The BioTek Instruments (Winooski, VT; USA) Cytation 1 cell imaging multi-mode reader has been cited as an affordable entry into automated digital quantitative microscopy along with multi-mode microplate detection.

This unique, patented design provides quantitative phenotypic cellular information along with well-based quantitative data. Cytation 1's multi-mode detection module includes high sensitivity filter-based fluorescence and a monochromator system for UV-Visible absorbance. Temperature control and shaking are standard; CO2/O2 control and reagent injectors are available as accessories.

The digital microscopy mode includes fluorescence and high contrast brightfield channels for visualization from 1.25 times to 60 times without the expense and complexity commonly associated with other digital microscopy systems. Furthermore, automated XY stage, focus, and LED intensity facilitate imaging throughput, especially during cell-based applications such as three-dimensional spheroid imaging. The multi-mode detection module includes sensitive filter-based fluorescence and luminescence along with monochromator-based UV-Visible absorbance for flexibility in a wide range of endpoint, kinetic, inject/read, and other assay types.

BioTek’s powerful Gen5 software makes image capture and plate reading easy. The latest Gen5 3.03 software offers new functionality for imaging and microplate reading, including spot counting for cellular image analysis and a fluorophore spectra utility for convenience during fluorescence detection protocol definition, and many others.

Cytation 1 can be integrated with BioTek’s BioStack microplate stacker or BioSpa 8 automated incubator to automate throughput and long-term live cell kinetic imaging. The instrument is compatible with a variety of sample vessels, including microplates, slides, cell culture dishes and flasks, hemocytometers, and the Take3 micro-volume plate.

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.